Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Abstract

Background Scarce data are available on what variables affect the risk of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of symptomatic COVID-19, and, particularly, the relationship with viral load. We aimed to analyse data from linked index cases of COVID-19 and their contacts to explore factors associated with transmission of SARS-CoV-2. Methods In this cohort study, patients were recruited as part of a randomised controlled trial done between March 17 and April 28, 2020, that aimed to assess if hydroxychloroquine reduced transmission of SARS-CoV-2. Patients with COVID-19 and their contacts were identified by use of the electronic registry of the Epidemiological Surveillance Emergency Service of Catalonia (Spain). Patients with COVID-19 included in our analysis were aged 18 years or older, not hospitalised, had quantitative PCR results available at baseline, had mild symptom onset within 5 days before enrolment, and had no reported symptoms of SARS-CoV-2 infections in their accommodation or workplace within the 14 days before enrolment. Contacts included were adults with a recent history of exposure and absence of COVID-19-like symptoms within the 7 days preceding enrolment. Viral load of contacts, measured by quantitative PCR from a nasopharyngeal swab, was assessed at enrolment, at day 14, and whenever the participant reported COVID-19-like symptoms. We assessed risk of transmission and developing symptomatic disease and incubation dynamics using regression analysis. We assessed the relationship of viral load and characteristics of cases (age, sex, number of days from reported symptom onset, and presence or absence of fever, cough, dyspnoea, rhinitis, and anosmia) and associations between risk of transmission and characteristics of the index case and contacts. Findings We identified 314 patients with COVID-19, with 282 (90%) having at least one contact (753 contacts in total), resulting in 282 clusters. 90 (32%) of 282 clusters had at least one transmission event. The secondary attack rate was 17% (125 of 753 contacts), with a variation from 12% when the index case had a viral load lower than 1 × 10⁶ copies per mL to 24% when the index case had a viral load of 1 × 10¹⁰ copies per mL or higher (adjusted odds ratio per log 10 increase in viral load 1•3, 95% CI 1•1-1•5). Increased risk of transmission was also associated with household contact (3•0, 1•59-5•65) and age of the contact (per year: 1•02, 1•01-1•04). 449 contacts had a positive PCR result at baseline. 28 (6%) of 449 contacts had symptoms at the first visit. Of 421 contacts who were asymptomatic at the first visit, 181 (43%) developed symptomatic COVID-19, with a variation from approximately 38% in contacts with an initial viral load lower than 1 × 10⁷ copies per mL to greater than 66% for those with an initial viral load of 1 × 10¹⁰ copies per mL or higher (hazard ratio per log 10 increase in viral load 1•12, 95% CI 1•05-1•20; p=0•0006). Time to onset of symptomatic disease decreased from a median of 7 da...

Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates

“…However, these people were initially identified from hospitalized patients and subsequent contact tracing, so there is some uncertainty with respect to timing of collection relative to stage of infection. Another study of 282 mildly symptomatic, but not hospitalized, patients found that viral loads greater than 1x10 10 copies/mL were associated with double the rate of transmission (24%) than viral loads below 1x10 6 copies/mL (Marks et al, 2021).…”

“…Multiple reports have indicated that viral load can differ by orders of magnitude across patients (Kissler et al, 2020;Lennon et al, 2020). Moreover, there is growing evidence amongst symptomatic patients that higher viral load can result in a higher risk of transmission (Kawasuji et al, 2020;Marks et al, 2021). To compare viral load in these students, we looked at the quantification of viral E gene RNA in the screening RT-qPCR test as a proxy for viral genomes.…”

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19

“…For the laboratory processing of the Liverpool samples, Ct values of 21-18 most likely reflect the 100 000 to 1 million RNA copies per mL, quantities below which virus cultures usually become negative and transmission risks are low. [22][23][24] Other laboratories place this threshold at a Ct of 30. 24 There is no international standardisation between laboratories and assays, leaving Ct calibration with viral load poorly reported and easy to misunderstand.…”

Comparative performance of SARS CoV-2 lateral flow antigen tests demonstrates their utility for high sensitivity detection of infectious virus in clinical specimens

“…5,6 Individuals are most infectious around the time of symptom onset, when viral loads in the upper respiratory tract are highest, 7,8 with recent studies confirming an association between viral load and increased transmission of SARS-CoV-2. 9 For asymptomatic individuals, infectivity and viral load dynamics involve a similar, limited, period of infectivity, and asymptomatic and pre-symptomatic contributions to spread in the community remain problematic. 10,11…”